Ascentage Pharma Group International vs OPKO Health
AAPG and OPK side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AAPG and OPK compare
OPKO Health grew revenue faster over the last twelve months (−8.3% versus −41.5% for Ascentage Pharma Group International).
OPKO Health keeps more of each dollar of sales as profit, with a net margin of −29.5% compared with −216% at Ascentage Pharma Group International.
OPKO Health scores higher on the StockData Score (8 against 3 for Ascentage Pharma Group International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AAPG | OPK |
|---|---|---|
| Size and price | ||
| Market cap | – | $1.3B |
| Share price | $14.62 | $1.68 |
| Change, 1 year | −55.6% | 27.3% |
| Change, 5 years | – | −61.4% |
| Beta (5Y) | 0.79 | 0.92 |
| Employees | 767 | 2,275 |
| StockData Score | ||
| Total score | 3 | 8 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 1 | 1 |
| Performance score | 1 | 2 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 2.5× |
| P/B | – | 1.1× |
| FCF yield | – | −10.8% |
| Fair value | – | $2.10 |
| Margin of safety | – | 20.0% |
| Growth | ||
| Revenue growth (TTM) | −41.5% | −8.3% (better) |
| Revenue growth, 5Y average | – | −15.8% |
| Profitability | ||
| Gross margin | 91.5% (better) | 56.6% |
| Operating margin | – | −17.5% |
| Net margin | −216% | −29.5% (better) |
| FCF margin | −209% | −27.0% (better) |
| Return on equity | −156% | −12.2% (better) |
| Return on invested capital | – | −8.5% |
| Financial health | ||
| Debt / equity | 1.50 | 0.00 (better) |
| Current ratio | 1.79 | 4.97 (better) |
| Altman Z-score | – | −0.28 |
| Piotroski F-score | – | 4 |
| Dividends and buybacks | ||
| Buyback yield | – | 3.3% |
| Shareholder yield | – | 3.3% |
| Ownership | ||
| Held by institutions | 0.00% | 27.2% |
| Held by insiders | 13.0% | 43.6% |
| Insider net buying, 12 months | – | −$13.2K |
| Short interest, % of float | – | 7.8% |
Go deeper
- AAPG stock overview
- AAPG income statement
- AAPG valuation and score
- OPK stock overview
- OPK income statement
- OPK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.